Dataset from A Phase II, Randomized, Multi-centre, Double-blind, Parallel-group, Dose-ranging, Exploratory Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 (Mesalazine) Once Daily
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007251
下载链接
链接失效反馈官方服务：
资源简介：
Evaluate the percentage of subjects in remission at the end of an 8-week treatment period for
three dose groups (SPD476 1.2 g/day, 2.4 g/day or 4.8 g/day, administered once daily).
创建时间：
2024-11-26
